Search research articles
Contact Us
Filters
Showing results (121-130 of 183) with videos related to
Page
of 19
Sort By:
Arxiv
|
June 19, 2020
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
Allison Koenecke, Michael Powell, Ruoxuan Xiong, et al.
Science Translational Medicine
|
July 8, 2016
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, et al.
Science Advances
|
February 20, 2026
Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia
Christopher Douville, Jeeun Parksong, Marco Dal Molin, et al.
Nature Communications
|
August 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Katharine M Wright, Sarah R DiNapoli, Michelle S Miller, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
Jarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
Oncotarget
|
April 18, 2013
Exomic sequencing of four rare central nervous system tumor types
Chetan Bettegowda, Nishant Agrawal, Yuchen Jiao, et al.
Cancer
|
January 6, 2021
Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma
Ashwini Shanmugam, Arun K Hariharan, Rifat Hasina, et al.
Elife
|
June 11, 2021
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
Allison Koenecke, Michael Powell, Ruoxuan Xiong, et al.
Nature Communications
|
September 7, 2021
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
Michael S Hwang, Michelle S Miller, Puchong Thirawatananond, et al.
Science Translational Medicine
|
July 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 183) with videos related to
Sort By:
Page
of 19
Arxiv
|
June 19, 2020
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
Allison Koenecke, Michael Powell, Ruoxuan Xiong, et al.
Science Translational Medicine
|
July 8, 2016
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, et al.
Science Advances
|
February 20, 2026
Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia
Christopher Douville, Jeeun Parksong, Marco Dal Molin, et al.
Nature Communications
|
August 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Katharine M Wright, Sarah R DiNapoli, Michelle S Miller, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
Jarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
Oncotarget
|
April 18, 2013
Exomic sequencing of four rare central nervous system tumor types
Chetan Bettegowda, Nishant Agrawal, Yuchen Jiao, et al.
Cancer
|
January 6, 2021
Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma
Ashwini Shanmugam, Arun K Hariharan, Rifat Hasina, et al.
Elife
|
June 11, 2021
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
Allison Koenecke, Michael Powell, Ruoxuan Xiong, et al.
Nature Communications
|
September 7, 2021
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
Michael S Hwang, Michelle S Miller, Puchong Thirawatananond, et al.
Science Translational Medicine
|
July 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, et al.
Page
of 19